|
January 8, 2007
Marquette General Cancer Center participates
in clinical trial for lung cancer
Patients sought for participation
The Marquette
General Cancer Center is participating in a nationwide clinical
trial to test a new drug in lung cancer. The ATLAS study will
focus on lung cancer patients whose tumors cannot be treated with
radiation or surgery.
Patients
who may be eligible for enrollment in the trial are those
with “locally advanced, recurrent, or metastatic,
non-small cell” lung cancer.
Marquette General is the only institution in Upper Michigan
and northeastern Wisconsin to make this clinical trial available
to local patients.
Eligible
patients will receive 4 cycles of chemotherapy and bevacizumab.
After 4 cycles, participants who do not have disease progression
will be randomized into either a bevacizumab + erlotinib
or bevacizumab + placebo group. |
 |
It is estimated
that approximately 1200 patients nationwide will be appropriate
for the trial, and Marquette General is seeking to enroll a minimum
of 10 patients. There is no additional cost to patients for the
medications or any other testing, such as lab work and CT scans,
that are required as part of this clinical. All portions for the
“standard” treatment” will be covered as usual
by the patient’s insurance.
In order to enroll in this trial, patients must be referred to
one of the medical oncologists associated with U.P. Hematology-Oncology
Associates on the medical staff of Marquette General Hospital.
These physicians comprise Dr.
Aaron Scholnik, Dr.
Sheetal Acharya and Dr.
Shahid Shekhani in Marquette at 906-225-3922; Dr.
Irina Sachelarie in Hancock at 906-483-1730; Dr.
Mohammad Nsour in Escanaba at 906-786-2172; Dr.
Gustavo Morel in Iron Mountain at
906-774-6257; and Dr.
Adnan Alkhalili in Sault Ste. Marie at 906-632-6013 or 877-823-6195.
Many of these oncologists provide outreach clinics in other communities
throughout the Upper Peninsula.
For more information on eligibility for enrollment in the trial,
please contact the Marquette General Cancer Center research department
at 906-225-3467, or 1-800-562-9753, extension 3467, or visit the
Marquette General website at www.mgh.org/cancer.
|
